Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/AP5> ?p ?o }
Showing triples 1 to 77 of
77
with 100 triples per page.
- AP5 abstract "AP5 or APV ((2R)-amino-5-phosphonovaleric acid; (2R)-amino-5-phosphonopentanoate) is a selective NMDA receptor antagonist that competitively inhibits the ligand (glutamate) binding site of NMDA receptors. AP5 blocks NMDA receptors in micromolar concentrations (~50 µM).AP5 blocks the cellular analog of classical conditioning in the sea slug Aplysia californica, and has similar effects on Aplysia long-term potentiation (LTP), since NMDA receptors are required for both. It is sometimes used in conjunction with the calcium chelator BAPTA to determine whether NMDARs are required for a particular cellular process. AP5/APV has also been used to study NMDAR-dependent LTP in the mammalian hippocampus.In general, AP5 is very fast-acting within in vitro preparations, and can block NMDA receptor action at a reasonably small concentration. The active isomer of AP5 is considered to be the D configuration, although many preparations are available as a racemic mixture of D- and L-isomers. It is useful to isolate the action of other glutamate receptors in the brain, i.e., AMPA and kainate receptors.AP5 can block the conversion of a silent synapse to an active one, since this conversion is NMDA receptor-dependent.AP5 was developed by Jeff Watkins and Harry Olverman.".
- AP5 iupacName "2-amino-5-phosphonopentanoic acid".
- AP5 thumbnail 2-Amino-5-phosphonovaleriansäure.svg?width=300.
- AP5 wikiPageExternalLink 10595.
- AP5 wikiPageID "702891".
- AP5 wikiPageLength "3859".
- AP5 wikiPageOutDegree "24".
- AP5 wikiPageRevisionID "670368345".
- AP5 wikiPageWikiLink AMPA.
- AP5 wikiPageWikiLink AMPA_receptor.
- AP5 wikiPageWikiLink AP-7_(drug).
- AP5 wikiPageWikiLink BAPTA.
- AP5 wikiPageWikiLink Calcium.
- AP5 wikiPageWikiLink California_sea_hare.
- AP5 wikiPageWikiLink Category:Amino_acids.
- AP5 wikiPageWikiLink Category:NMDA_receptor_antagonists.
- AP5 wikiPageWikiLink Category:Phosphonic_acids.
- AP5 wikiPageWikiLink Chelation.
- AP5 wikiPageWikiLink Classical_conditioning.
- AP5 wikiPageWikiLink Competitive_inhibition.
- AP5 wikiPageWikiLink Glutamic_acid.
- AP5 wikiPageWikiLink Harry_Olverman.
- AP5 wikiPageWikiLink In_vitro.
- AP5 wikiPageWikiLink Isomer.
- AP5 wikiPageWikiLink Jeff_Watkins.
- AP5 wikiPageWikiLink Kainate_receptor.
- AP5 wikiPageWikiLink Kainic_acid.
- AP5 wikiPageWikiLink Long-term_potentiation.
- AP5 wikiPageWikiLink NMDA_receptor.
- AP5 wikiPageWikiLink NMDA_receptor_antagonist.
- AP5 wikiPageWikiLink Racemic_mixture.
- AP5 wikiPageWikiLink Silent_synapse.
- AP5 wikiPageWikiLinkText "AP5".
- AP5 wikiPageWikiLinkText "APV".
- AP5 imagefile "2".
- AP5 imagesize "240".
- AP5 iupacname "2".
- AP5 verifiedfields "changed".
- AP5 verifiedrevid "477236292".
- AP5 watchedfields "changed".
- AP5 wikiPageUsesTemplate Template:Cascite.
- AP5 wikiPageUsesTemplate Template:Chembox.
- AP5 wikiPageUsesTemplate Template:Chembox_Hazards.
- AP5 wikiPageUsesTemplate Template:Chembox_Identifiers.
- AP5 wikiPageUsesTemplate Template:Chembox_Properties.
- AP5 wikiPageUsesTemplate Template:Chemspidercite.
- AP5 wikiPageUsesTemplate Template:Doi.
- AP5 wikiPageUsesTemplate Template:Glutamate_receptor_ligands.
- AP5 wikiPageUsesTemplate Template:Stdinchicite.
- AP5 subject Category:Amino_acids.
- AP5 subject Category:NMDA_receptor_antagonists.
- AP5 subject Category:Phosphonic_acids.
- AP5 hypernym Antagonist.
- AP5 type Biomolecule.
- AP5 type ChemicalCompound.
- AP5 type ChemicalSubstance.
- AP5 type Drug.
- AP5 type Antagonist.
- AP5 type Biomolecule.
- AP5 type ChemicalObject.
- AP5 type Thing.
- AP5 type Q11173.
- AP5 comment "AP5 or APV ((2R)-amino-5-phosphonovaleric acid; (2R)-amino-5-phosphonopentanoate) is a selective NMDA receptor antagonist that competitively inhibits the ligand (glutamate) binding site of NMDA receptors. AP5 blocks NMDA receptors in micromolar concentrations (~50 µM).AP5 blocks the cellular analog of classical conditioning in the sea slug Aplysia californica, and has similar effects on Aplysia long-term potentiation (LTP), since NMDA receptors are required for both.".
- AP5 label "AP5".
- AP5 sameAs Q209309.
- AP5 sameAs 2-Amino-5-phosphonovaleriansäure.
- AP5 sameAs APV_(antagonista_NMDAR).
- AP5 sameAs ایپی_۵.
- AP5 sameAs Acide_2-amino-5-phosphonovalérique.
- AP5 sameAs D-(-)-2-アミノ-5-ホスホノペンタン酸.
- AP5 sameAs m.03424p.
- AP5 sameAs AP5.
- AP5 sameAs AP5.
- AP5 sameAs Q209309.
- AP5 wasDerivedFrom AP5?oldid=670368345.
- AP5 depiction 2-Amino-5-phosphonovaleriansäure.svg.
- AP5 isPrimaryTopicOf AP5.